Brevan Howard Capital Management LP Acquires Shares of 20,171 Tempus AI, Inc. (NASDAQ:TEM)

Brevan Howard Capital Management LP purchased a new stake in shares of Tempus AI, Inc. (NASDAQ:TEM - Free Report) in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm purchased 20,171 shares of the company's stock, valued at approximately $682,000.

A number of other hedge funds also recently modified their holdings of the business. Victory Capital Management Inc. acquired a new position in shares of Tempus AI in the 4th quarter worth approximately $216,000. China Universal Asset Management Co. Ltd. bought a new stake in shares of Tempus AI during the 4th quarter valued at about $1,091,000. Mirae Asset Global Investments Co. Ltd. acquired a new stake in Tempus AI during the fourth quarter worth approximately $178,000. abrdn plc bought a new stake in Tempus AI in the fourth quarter worth approximately $2,784,000. Finally, Dakota Wealth Management lifted its stake in Tempus AI by 189.7% in the fourth quarter. Dakota Wealth Management now owns 60,668 shares of the company's stock valued at $2,048,000 after buying an additional 39,724 shares during the period. Institutional investors and hedge funds own 24.22% of the company's stock.

Analyst Upgrades and Downgrades

TEM has been the subject of several recent analyst reports. TD Cowen reaffirmed a "buy" rating and set a $74.00 price objective (up previously from $58.00) on shares of Tempus AI in a research report on Wednesday, February 5th. BTIG Research started coverage on shares of Tempus AI in a research report on Monday, April 21st. They set a "buy" rating and a $60.00 price objective on the stock. JPMorgan Chase & Co. downgraded Tempus AI from an "overweight" rating to a "neutral" rating and raised their target price for the company from $50.00 to $55.00 in a research note on Tuesday, February 25th. Guggenheim reaffirmed a "buy" rating on shares of Tempus AI in a research note on Tuesday, February 25th. Finally, William Blair reissued a "market perform" rating on shares of Tempus AI in a research note on Tuesday, February 25th. Six analysts have rated the stock with a hold rating and seven have issued a buy rating to the stock. According to data from MarketBeat.com, the company has an average rating of "Moderate Buy" and an average target price of $61.50.

Insiders Place Their Bets

In other Tempus AI news, CAO Ryan M. Bartolucci sold 6,059 shares of the company's stock in a transaction dated Thursday, February 13th. The shares were sold at an average price of $80.00, for a total transaction of $484,720.00. Following the sale, the chief accounting officer now directly owns 47,000 shares of the company's stock, valued at $3,760,000. This represents a 11.42 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, EVP Erik Phelps sold 61,582 shares of the business's stock in a transaction dated Tuesday, February 18th. The stock was sold at an average price of $82.36, for a total value of $5,071,893.52. Following the transaction, the executive vice president now directly owns 153,080 shares of the company's stock, valued at $12,607,668.80. The trade was a 28.69 % decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 4,237,561 shares of company stock valued at $251,210,331. Insiders own 27.60% of the company's stock.

Tempus AI Stock Down 5.9 %

Shares of NASDAQ TEM traded down $3.88 during trading on Friday, hitting $61.34. The stock had a trading volume of 15,472,133 shares, compared to its average volume of 6,015,116. The firm has a fifty day moving average of $48.39 and a two-hundred day moving average of $51.05. The company has a market capitalization of $10.56 billion and a PE ratio of -7.86. The company has a debt-to-equity ratio of 8.17, a current ratio of 2.69 and a quick ratio of 2.55. Tempus AI, Inc. has a 12 month low of $22.89 and a 12 month high of $91.45.

Tempus AI (NASDAQ:TEM - Get Free Report) last issued its quarterly earnings data on Tuesday, May 6th. The company reported ($0.24) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.27) by $0.03. The firm had revenue of $255.74 million during the quarter, compared to the consensus estimate of $248.13 million. The firm's revenue for the quarter was up 75.4% on a year-over-year basis. As a group, equities research analysts forecast that Tempus AI, Inc. will post -6.15 EPS for the current fiscal year.

About Tempus AI

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.